Cloning, expression and identification by immunohistochemistry of humanized single-chain variable fragment antibody against hepatitis C virus core protein

Polish Journal of Microbiology

Volumn 60, Issue 1, 2011, Pages 13-17

  Lun, Yong Zhi ^a,b   Jun, Cheng ^b   Zhong, Yan Wei ^b   Yu, Zeng Guo ^a   Wang, Qi ^b   Wang, Fang ^c   Feng, Jie ^a  

^a DALIAN UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c NONE

Author keywords

Core protein; Hepatitis C virus; Phage display; Single chain variable fragment antibody

Indexed keywords

AMINO ACID; CORE PROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

AMINO ACID SEQUENCE; ANTIBODY LIBRARY; ANTIBODY SPECIFICITY; ANTIGEN DETECTION; ARTICLE; BACTERIOPHAGE; CLONE; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR CLONING; NONHUMAN;

HEPATITIS C VIRUS;

EID: 79955458128     PISSN: 17331331     EISSN: None     Source Type: Journal    
DOI: 10.33073/pjm-2011-002     Document Type: Article

References (20)

1. Aoyagi K., C. Ohue and K. Iida. 1999. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J. Clin. Microbiol. 37: 1802-1808. (Pubitemid 29235226)
2. Armstrong G.L. 2003. Commentary: modeling the epidemiology of hepatitis C and its complications. Int. J. Epidemiol. 32: 725-726. (Pubitemid 37304629)
3. Canaan-Haden L., M. Ayala and M.E. Fernandez-de-Cossio. 1995. Purification and application of a single-chain Fv antibody fragment specific to hepatitis B virus surface antigen. Biotechniques 19: 606-612.
4. Di Bisceglie A.M. 2000. Natural history of hepatitis C: its impact on clinical management. Hepatology 31: 1014-1018. (Pubitemid 30169951)
5. Dickson R.C., M. Mizokami and E. Orito. 1999. Quantification of serum HCV core antigen by a fluorescent enzyme immunoassay in liver transplant recipients with recurrent hepatitis C: clinical and virologic implications. Transplantation. 68: 1512.
6. Hoogenboom H.R., A.P. de Bruine and S.E. Hufton. 1998. Anti-body phage display technology and its applications. Immunotechnology 4: 1-20. (Pubitemid 28302180)
7. Houghton M., A. Weiner and J. Han. 1991. Molecular biology of the hepatitis C virus: implications for diagnosis, development, and control of viral disease. Hepatology 14: 381.
8. Kittlesen D.J., K.A. Chianese-Bullock and Z.Q. Yao. 2000. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J. Clin. Investig. 106: 1239-1249.
9. Hagedorn C.H. and C.M. Rice. 2000. The hepatitis C viruses. Springer-Verlag KG Berlin, Germany.
10. Lamarre A. and P.J. Talbot. 1997. Characterization of phage-displayed recombinant anti-idiotypic antibody fragments against cCoronavirus neutralizing monoclonal antibodies. Viral. Immunol. 10: 175-182. (Pubitemid 28066169)
11. Large M.K., D.J. Kittlesen and Y.S. Hahn. 1999. Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence. J. Immunol. 162: 931-938. (Pubitemid 29035418)
12. Marks J.D., H.R. Hoogenboom and T.P. Bonnert. 1991. By-immunization human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222: 581-597.
13. Menez R., M. Bossus and B.H. Muller. 2003. Crystal structure of a hydrophobic immunodominant antigenic site on hepatitis C virus core protein complexed to monoclonal antibody 19D9D6. J. Immunol. 170: 1917-1924. (Pubitemid 36197410)
14. Nelson D.R., C.G. Marousis and G.L. Davis. 1997. The role of hepatitis C virus-specific cytotoxic lymphocytes in chronic hepatitis C. J. Immunol. 158: 1473-1481. (Pubitemid 127469976)
15. Reed K.E. and C.M. Rice. 2000. Overview of hepatitis C virus genome stucture, polyprotein processing, and protein properties. Curr. Top. Microbiol. Immunol. 242: 55-84. (Pubitemid 29467521)
16. Rondon U. and W.A. Marasco. 1997. Intracellular antibodies (intrabodies) for gene therapy of infectious disease. Annu. Rev. Microbiol. 51: 257-283. (Pubitemid 27433050)
17. Songsivilai S., T. Dharakul and R. Kunkitti. 1996. Molecular cloning and expression of hepatitis C virus core protein and production of monoclonal antibodies to the recombinant protein. Asian Pac J Allergy Immunol. 14: 31-41. (Pubitemid 27397406)
18. Stoll-Keller F., H. Barth and S. Fafi-Kremer. 2009. Development of hepatitis C virus vaccines: challenges and progress. Expert Rev. Vaccines 8: 333-345.
19. Tanaka E., C. Ohue and K. Aoyagi. 2000. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) ore antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA. Hepatology 32: 388.
20. Zhong Y., J. Cheng and S. Shi. 2001. Screening and characterization of human phage antibody to hepatitis C core antigen (in Chinese). Zhonghua Gan Zang Bing Za Zhi 9: 217-219.